Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonazepam vs Midazolam for Seizure Clusters
NCT06056349Recruiting
- Sponsor
- National Institute of Neurology and Neurosurgery
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of clonazepam and midazolam in seizure cluster (3 arms), sponsored by National Institute of Neurology and Neurosurgery. Primary endpoint: Change from baseline seizure frequency at 6 months. Started May 2023; status: recruiting.
02
Drugs
clonazepammidazolam
03
Conditions
seizure cluster
Beyond the preview
Go deeper on NCT06056349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06056349.